Mustang Bio
About:
Mustang Bio is a clinical-stage biopharmaceutical company .
Website: http://www.mustangbio.com/
Top Investors: Runway Growth Capital, Horizon Technology Finance, National Institutes of Health, California Institute for Regenerative Medicine
Description:
Mustang Bio is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells. The products under development are - CD123, CD20, and CS1.
$219M
$10M to $50M
New York, New York, United States
2015-01-01
info(AT)mustangbio.com
Michael S. Weiss Weiss
51-100
2024-10-24
Public
© 2025 bioDAO.ai